Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 5,500 shares at $50.97 ($276K) on 2018-06-11, disclosed to the SEC on 2018-06-13.
Scheduled sale ($276k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.14 | 4,991 | $250K | 90.6% |
| 2 | $50.97 | 509 | $26K | 9.4% |
| Total | $50.22 avg | 5,500 | $276K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |